kidney pain with semaglutide Semaglutide: A Breakthrough for Chronic Disease Semaglutide and Urinary Tract Infections:

INS-1 832/3 SNAP/FLAG-hGLP-1R WT and V229A cells were generated in house from INS-1 832/3 GLP-1R KO cells following transfection with pSNAP/FLAG-hGLP-1R (Cisbio) or pSNAP/FLAG-hGLP-1R-V229A (generated in house by site-directed mutagenesis, see below), followed by selection with 1 mg/mL G418 sulphate (A1720, Sigma Aldrich)

White CM, Lee JY

Our providers start patients on a low dose to minimize side effects, then gradually increase the dosage based on tolerance, results, and individual goals

This finding is particularly relevant because fatty liver disease affects a substantial percentage of people with obesity and can progress to serious conditions like cirrhosis and liver cancer

However, this association is purely observational, and further research is required to establish a causal relationship (122)

As of now (early 2025), retatrutide is not yet available to the public